|
 Teva, the world's largest generic drugmaker, said the settlement
"does not establish any wrongdoing on the part of the company" and
denied contributing to opioid abuse in Oklahoma.
Claims against Teva focused on the branded opioid products Actiq and
Fentora as well as generic painkillers it produced.
The trial against Israel-based Teva, along with Johnson & Johnson,
was set to begin on Tuesday. The lawsuit alleged the companies'
marketing of the painkiller was to blame for the opioid epidemic.
In a statement, Janssen Pharmaceuticals Inc, a J&J subsidiary, said
it had acted responsibly and was ready for trial. It said it
disagreed with what it called Oklahoma's "overly expansive theories"
of public nuisance law, and said they should not apply in this
situation.
"At the same time, as with all litigation, if an appropriate
resolution is possible that avoids the expense and uncertainty of a
trial, we are always open to that option," the company said in a
statement.
Oklahoma Attorney General Mike Hunter has alleged that J&J and Teva,
along with OxyContin maker Purdue Pharma LP, carried out deceptive
marking campaigns that downplayed opioids' addictive risks while
overstating their benefits.
The state also alleges the companies' actions created an oversupply
of painkillers and a public nuisance that will cost $12.7 billion to
$17.5 billion to remedy.
Oklahoma resolved its claims against Purdue Pharma LP in March for
$270 million.
[to top of second column] |
The Oklahoma case is being closely watched by plaintiffs in other
opioid cases, particularly some 1,850 mostly municipal and state
governments that have sued the same drugmakers in the federal court
in Ohio.
"Teva is pleased to put the Oklahoma case behind it and remains
prepared to vigorously defend claims against the company, including
the upcoming federal court trial in Cleveland where the majority of
the cases are pending," the company said.
Attorney General Hunter's office said in a statement the money would
be used to address the opioid crisis in Oklahoma and that the J&J
case is still scheduled to go to trial on Tuesday before Cleveland
County District Judge Thad Balkman.
"Nearly all Oklahomans have been negatively impacted by this deadly
crisis and we look forward to Tuesday, where we will prove our case
against Johnson & Johnson and its subsidiaries," Hunter said in a
statement.
(Reporting by Nate Raymond and Ari Rabinovitch; Editing by Jane
Merriman and Lisa Shumaker)
[© 2019 Thomson Reuters. All rights
reserved.] Copyright 2019 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |
